Kyle M. Walsh

11.4k total citations · 1 hit paper
120 papers, 4.6k citations indexed

About

Kyle M. Walsh is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Kyle M. Walsh has authored 120 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 28 papers in Genetics and 23 papers in Genetics. Recurrent topics in Kyle M. Walsh's work include Glioma Diagnosis and Treatment (28 papers), Epigenetics and DNA Methylation (22 papers) and Acute Lymphoblastic Leukemia research (12 papers). Kyle M. Walsh is often cited by papers focused on Glioma Diagnosis and Treatment (28 papers), Epigenetics and DNA Methylation (22 papers) and Acute Lymphoblastic Leukemia research (12 papers). Kyle M. Walsh collaborates with scholars based in United States, China and United Kingdom. Kyle M. Walsh's co-authors include Margaret Wrensch, Melike Pekmezci, Quinn T. Ostrom, Jill S. Barnholtz‐Sloan, Judith Schwartzbaum, Luc Bauchet, Michelle C. Turner, James L. Fisher, Isabelle Deltour and Faith G. Davis and has published in prestigious journals such as Science, New England Journal of Medicine and Circulation.

In The Last Decade

Kyle M. Walsh

116 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The epidemiology of glioma in adults: a "state of the science" review

2014 1.6k citations Quinn T. Ostrom, Melike Pekmezci et al. Neuro-Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle M. Walsh United States	29	1.9k	1.4k	1.0k	789	637	120	4.6k
Peter A.E. Sillevis Smitt Netherlands	46	2.0k 1.0×	1.7k 1.2×	843 0.8×	869 1.1×	791 1.2×	129	7.2k
Michael A. Grotzer Switzerland	41	2.7k 1.4×	1.5k 1.1×	796 0.8×	758 1.0×	793 1.2×	223	5.9k
Mika Watanabe Japan	43	1.8k 0.9×	909 0.7×	1.1k 1.0×	1.3k 1.6×	1.4k 2.2×	344	6.9k
David W. White United States	18	2.8k 1.4×	1.3k 1.0×	2.0k 1.9×	348 0.4×	545 0.9×	36	5.7k
Seung‐Ki Kim South Korea	42	1.9k 1.0×	2.1k 1.5×	773 0.7×	1.1k 1.4×	776 1.2×	336	6.9k
Brian V. Nahed United States	35	1.3k 0.7×	1.3k 0.9×	679 0.6×	1.1k 1.4×	849 1.3×	176	5.5k
Katherine B. Peters United States	35	1.3k 0.7×	2.3k 1.7×	803 0.8×	1.1k 1.4×	1.1k 1.8×	230	4.6k
Stewart Goldman United States	48	2.4k 1.3×	3.0k 2.1×	543 0.5×	1.2k 1.5×	903 1.4×	178	6.7k
Filip De Vos Belgium	37	1.2k 0.6×	734 0.5×	493 0.5×	1.0k 1.3×	1.0k 1.6×	281	5.0k
Mehmet Koçak United States	40	2.6k 1.3×	3.3k 2.4×	1.1k 1.0×	1.3k 1.6×	1.6k 2.6×	150	7.1k

Countries citing papers authored by Kyle M. Walsh

Since Specialization

Citations

This map shows the geographic impact of Kyle M. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle M. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle M. Walsh more than expected).

Fields of papers citing papers by Kyle M. Walsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle M. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle M. Walsh. The network helps show where Kyle M. Walsh may publish in the future.

Co-authorship network of co-authors of Kyle M. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle M. Walsh. A scholar is included among the top collaborators of Kyle M. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle M. Walsh. Kyle M. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Semmes, Eleanor C., Ashley N. Nelson, Jillian H. Hurst, et al.. (2024). In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions. Journal of Clinical Investigation. 135(1). 4 indexed citations

Davis, Elizabeth, et al.. (2024). Psychosocial burden after the death of a child from cancer: Results of a bereaved parent survey. Death Studies. 49(7). 954–962.

Kaplan, Samantha, et al.. (2023). Systematic review and meta-analysis of the effect of adverse childhood experiences (ACEs) on brain-derived neurotrophic factor (BDNF) levels. Psychoneuroendocrinology. 151. 106071–106071. 13 indexed citations

Darabi, Sourat, Joanne Xiu, Santosh Kesari, et al.. (2023). Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. Medical Oncology. 40(7). 197–197. 10 indexed citations

Lindsay, Holly, Sylvia Cheng, Paul G. Fisher, et al.. (2023). Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group. Neuro-Oncology Advances. 5(1). vdad130–vdad130. 1 indexed citations

Walsh, Kyle M., Mackenzie Price, Corey Neff, et al.. (2023). The joint impacts of sex and race/ethnicity on incidence of grade 1 versus grades 2–3 meningioma across the lifespan. Neuro-Oncology Advances. 5(Supplement_1). i5–i12. 10 indexed citations

Li, Shaobo, Christian M. Hagen, Ulrik Kristoffer Stoltze, et al.. (2023). Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus. Neuro-Oncology. 25(9). 1709–1720. 8 indexed citations

Broom, Alex, Katherine Kenny, Michelle Peterie, et al.. (2023). The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice. Clinical Cancer Research. 29(9). 1670–1677. 7 indexed citations

Price, Mackenzie, Carol Kruchko, Kristin Waite, et al.. (2023). Association of county-level socioeconomic status with meningioma incidence and outcomes. Neuro-Oncology. 26(4). 749–763. 4 indexed citations

10.

Li, Shaobo, Charleston W. K. Chiang, Swe Swe Myint, et al.. (2022). Localized variation in ancestral admixture identifies pilocytic astrocytoma risk loci among Latino children. PLoS Genetics. 18(9). e1010388–e1010388. 1 indexed citations

11.

Li, Shaobo, Xiaowu Gai, Swe Swe Myint, et al.. (2022). Mitochondrial 1555 G>A variant as a potential risk factor for childhood glioblastoma. Neuro-Oncology Advances. 4(1). vdac045–vdac045. 2 indexed citations

12.

Walsh, Kyle M., Corey Neff, Melissa L. Bondy, et al.. (2022). Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics. Neuro-Oncology. 25(2). 398–406. 15 indexed citations

13.

Zhao, Lingling, Hongliang Liu, Sheng Luo, et al.. (2020). Associations between genetic variants of KIF5B, FMN1, and MGAT3 in the cadherin pathway and pancreatic cancer risk. Cancer Medicine. 9(24). 9620–9631. 1 indexed citations

14.

Zhang, Chenan, Joseph L. Wiemels, Helen M. Hansen, et al.. (2018). Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk. Cancer Epidemiology Biomarkers & Prevention. 27(10). 1151–1158. 5 indexed citations

15.

Ohba, Shigeo, Joydeep Mukherjee, Andrew Mancini, et al.. (2016). Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. Cancer Research. 76(22). 6680–6689. 50 indexed citations

16.

Ojha, Juhi, Veryan Codd, Christopher P. Nelson, et al.. (2016). Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1043–1049. 50 indexed citations

17.

Bell, Robert J.A., H. Tomas Rube, Alex Kreig, et al.. (2015). The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science. 348(6238). 1036–1039. 398 indexed citations

18.

Walsh, Kyle M., Adam J. de Smith, Helen M. Hansen, et al.. (2015). A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer Research. 75(22). 4884–4894. 31 indexed citations

19.

Walsh, Kyle M., Ivan P. Gorlov, Helen M. Hansen, et al.. (2012). Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans. Cancer Epidemiology Biomarkers & Prevention. 22(2). 251–260. 27 indexed citations

20.

Clendenning, Mark, Shuying Sun, Kyle M. Walsh, et al.. (2008). Origins and Prevalence of the American Founder Mutation of MSH2. Cancer Research. 68(7). 2145–2153. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact